Rareton, NJ, United States of America

Michael McMillian



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2007-2012

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael McMillian: Innovator in Neurological Research

Introduction

Michael McMillian is a prominent inventor based in Rareton, New Jersey. He has made significant contributions to the field of neuroscience, particularly in the area of microglial activation and its implications for neurological health. With a total of five patents to his name, McMillian's work is at the forefront of innovative treatments for central nervous system disorders.

Latest Patents

McMillian's latest patents focus on methods of suppressing microglial activation in the Central Nervous System (CNS). These patents describe techniques for ameliorating or treating the neurological effects of cerebral ischemia and cerebral inflammation. Additionally, he has developed methods for combating specific diseases that affect the CNS by administering compounds that bind to microglial receptors, thereby preventing or reducing microglial activation. His patents also include methods for screening compounds that can suppress or reduce microglial activation, which is crucial for advancing therapeutic strategies.

Career Highlights

Michael McMillian is currently associated with Cognosci, Incorporated, where he continues to push the boundaries of neurological research. His work has garnered attention for its potential to transform treatment approaches for various CNS-related conditions. McMillian's innovative methods are paving the way for new therapies that could significantly improve patient outcomes.

Collaborations

Throughout his career, McMillian has collaborated with notable colleagues, including Daniel T. Laskowitz and William D. Matthew. These partnerships have enhanced the scope and impact of his research, contributing to the advancement of knowledge in the field of neuroscience.

Conclusion

Michael McMillian's contributions to the field of neurological research are noteworthy, particularly in the area of microglial activation. His innovative patents and collaborations reflect a commitment to improving treatments for CNS disorders. McMillian's work continues to inspire advancements in medical science and offers hope for those affected by neurological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…